This full-day session will feature a number of speakers who will cover various topics, from PSA tests and modern imaging (MRI and PSMA PET) to biopsy decisions and the evolving treatment landscape, including robotic surgery, radiation and active surveillance within the Monash Health shared-care pathway.
We will also focus on managing post-treatment issues, survivorship, and advanced disease — including novel systemic therapies, androgen deprivation and cardiovascular risk.
Through case discussions and open Q&A, our goal is to strengthen collaboration and improve prostate cancer care across our local community.
What’s on the agenda
- What’s new with PSA screening
- How prostate cancer diagnosis has been transformed
- MRI and PSMA PET: how it has changed practice
- Helping patients decide between surgery and radiation
- Active surveillance: Monash Health’s GP shared-care pathway
- Managing men on hormone therapy in general practice
- Side effects of ADT: cardiovascular risk, bone health and more
RACGP CPD accreditation in progress.
Registrations close Friday, 3 July 2026.
